Blood Consultative Committee

The Blood Consultative Committee works with the national executive blood bodies to develop advice and recommendations on regulatory aspects of blood banks, blood establishments and blood processes.

Role of the committee

The primary objectives of the committee are to:

  • advise and provide information to representatives of the national executive blood bodies, blood bank consultants, Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC) , Serious Hazards of Transfusion (SHOT), Haemophilia Society, Institute of Biomedical Sciences, British Society of Haematology, National Blood transfusion Committees, Clinical Pathology Accreditation (CPA), the wider Department of Health (DH) and other government departments with respect to other regulatory aspects of blood banks, blood establishments and blood processes
  • provide a forum for consultation and two-way discussion regarding proposed regulatory changes relating to the practical aspects of implementations
  • provide a forum to raise and take forward actions on strategic issues

At least 2 meetings will be held a year. The meeting will be chaired by a senior manager of the MHRA who will also provide the secretary.

Items to be discussed may include:

  • regulatory and EU matters related to blood safety
  • the performance and operation of the haemovigilance system and the Licensing Office
  • interpretation of the principles of Good Manufacturing Practice (GMP) by the Competent Authority
  • compliance by blood banks and blood establishments (in general) with GMP and Good Distribution Practice (GDP) (feedback from inspections)
  • implementation of changes based upon newly emerging scientific evidence

Members

The members will represent:

  • MHRA good medical practice inspectors
  • policy group of MHRA’s Inspections, Enforcement and Standards Division
  • MHRA Devices Division
  • SHOT
  • hospital blood banks
  • Haemophilia Society
  • Department of Health

Minutes

Meeting: 6 February 2018

6 February 2018: minutes (PDF, 114KB, 6 pages)

6 February 2018: Blood Consultative Committee Slide Deck (PDF, 527KB, 72 pages)

Meeting: 1 November 2016

November 2016: Agenda (PDF, 95.8KB, 1 page)

November 2016: minutes and associated papers (PDF, 1.09MB, 36 pages)

Meeting: 17 March 2016

March 2016: minutes and associated papers (PDF, 2.2MB, 70 pages)

Meeting: 23 September 2015

23 September 2015 : minutes (PDF, 197KB, 2 pages)

March 2015: newsletter in lieu of meeting

Blood Consultative Committee newsletter March 2015 (PDF, 448KB, 13 pages)

Meeting: 2 October 2014

2 October 2014: minutes (PDF, 88KB, 4 pages)

Presentations and papers

Blood Consultative Committe - draft terms of referrence - 23 September 2015 (PDF, 95.2KB, 2 pages)

Involving people - 23 September 2015 (PDF, 164KB, 6 pages)

MHRA GCP forum demo - 23 September 2015 (PDF, 267KB, 9 pages)

SABRE update: October 2014 (PDF, 373KB, 9 pages)

JPAC - Concessionary Release Limits for Leucocyte Depletion: October 2014 (PDF, 454KB, 10 pages)

Highlights from the annual SHOT report 2013: October 2014 (PDF, 1.01MB, 18 pages)

GMP Inspection Deficiencies 2013

Previous minutes are on the committees pages on the National Archives